rs75352646

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018026.4(PACS1):​c.102G>A​(p.Pro34Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00263 in 1,443,956 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 38 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 30 hom. )

Consequence

PACS1
NM_018026.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0640

Publications

0 publications found
Variant links:
Genes affected
PACS1 (HGNC:30032): (phosphofurin acidic cluster sorting protein 1) This gene encodes a protein with a putative role in the localization of trans-Golgi network (TGN) membrane proteins. Mouse and rat homologs have been identified and studies of the homologous rat protein indicate a role in directing TGN localization of furin by binding to the protease's phosphorylated cytosolic domain. In addition, the human protein plays a role in HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the TGN, thereby enabling HIV-1 to escape immune surveillance. [provided by RefSeq, Jul 2008]
PACS1 Gene-Disease associations (from GenCC):
  • Schuurs-Hoeijmakers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 11-66070588-G-A is Benign according to our data. Variant chr11-66070588-G-A is described in ClinVar as Benign. ClinVar VariationId is 129868.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.064 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0138 (2091/151352) while in subpopulation AFR AF = 0.0472 (1955/41418). AF 95% confidence interval is 0.0455. There are 38 homozygotes in GnomAd4. There are 978 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2091 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PACS1NM_018026.4 linkc.102G>A p.Pro34Pro synonymous_variant Exon 1 of 24 ENST00000320580.9 NP_060496.2 Q6VY07-1A0A024R5H6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PACS1ENST00000320580.9 linkc.102G>A p.Pro34Pro synonymous_variant Exon 1 of 24 1 NM_018026.4 ENSP00000316454.4 Q6VY07-1

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2087
AN:
151244
Hom.:
38
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0472
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00651
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.000192
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.00166
AC:
153
AN:
92258
AF XY:
0.00117
show subpopulations
Gnomad AFR exome
AF:
0.0495
Gnomad AMR exome
AF:
0.00236
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000165
Gnomad OTH exome
AF:
0.00232
GnomAD4 exome
AF:
0.00132
AC:
1712
AN:
1292604
Hom.:
30
Cov.:
31
AF XY:
0.00111
AC XY:
707
AN XY:
638002
show subpopulations
African (AFR)
AF:
0.0516
AC:
1369
AN:
26520
American (AMR)
AF:
0.00286
AC:
81
AN:
28306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22316
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28976
South Asian (SAS)
AF:
0.0000568
AC:
4
AN:
70406
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32858
Middle Eastern (MID)
AF:
0.00220
AC:
9
AN:
4082
European-Non Finnish (NFE)
AF:
0.0000790
AC:
81
AN:
1025500
Other (OTH)
AF:
0.00313
AC:
168
AN:
53640
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
81
162
243
324
405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0138
AC:
2091
AN:
151352
Hom.:
38
Cov.:
32
AF XY:
0.0132
AC XY:
978
AN XY:
73952
show subpopulations
African (AFR)
AF:
0.0472
AC:
1955
AN:
41418
American (AMR)
AF:
0.00651
AC:
99
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10392
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.000192
AC:
13
AN:
67632
Other (OTH)
AF:
0.0105
AC:
22
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
107
214
322
429
536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
3
Bravo
AF:
0.0159

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Inborn genetic diseases Benign:1
Jun 14, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Schuurs-Hoeijmakers syndrome Benign:1
Jan 10, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
11
DANN
Benign
0.88
PhyloP100
0.064
PromoterAI
0.051
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75352646; hg19: chr11-65838059; API